DNA topoisomerases pass DNA strands through each other, a function essential for all DNA metabolic processes that create supercoils or entanglements of DNA. Topoisomerases play an ambivalent role in nuclear genome maintenance: Deficiency compromises gene transcription, replication and chromosome segregation, while the inherent DNA-cleavage activity of the enzymes endangers DNA integrity. Indeed, many DNA-damaging agents act through enhancing topoisomerase DNA cleavage. Mitochondrial DNA (mtDNA) clearly requires topoisomerase activity for transcription and replication, because it is a closed, double-stranded DNA molecule. Three topoisomerases have so far been found in mammalian mitochondria (I, IIβ, IIIα), but their precise role in mtDNA metabolism, mitochondrial maintenance and respiratory function remains mostly unclear. It is a reasonable surmise that these enzymes exhibit similar ambiguity with respect to genome maintenance and gene transcription as their nuclear counterparts. Here, we review what is known about the physiological roles of mitochondrial topoisomerases and draft three scenarios of how these enzymes possibly contribute to ageingrelated mtDNA attrition and respiratory chain dysfunction. These scenarios are: mtDNA attrition by exogenously stimulated topoisomerase DNA cleavage, unbalancing of mitochondrial and nuclear transcription by direct effects on mitochondrial transcription, and contributions to enhanced mtDNA entanglement and recombination.
DNA topoisomerases pass DNA strands through each other, a function essential for all DNA metabolic processes that create supercoils or entanglements of DNA. Topoisomerases play an ambivalent role in nuclear genome maintenance: Deficiency compromises gene transcription, replication and chromosome segregation, while the inherent DNA-cleavage activity of the enzymes endangers DNA integrity. Indeed, many DNA-damaging agents act through enhancing topoisomerase DNA cleavage. Mitochondrial DNA (mtDNA) clearly requires topoisomerase activity for transcription and replication, because it is a closed, double-stranded DNA molecule. Three topoisomerases have so far been found in mammalian mitochondria (I, IIβ, IIIα) , but their precise role in mtDNA metabolism, mitochondrial maintenance and respiratory function remains mostly unclear. It is a reasonable surmise that these enzymes exhibit similar ambiguity with respect to genome maintenance and gene transcription as their nuclear counterparts. Here, we review what is known about the physiological roles of mitochondrial topoisomerases and draft three scenarios of how these enzymes possibly contribute to ageingrelated mtDNA attrition and respiratory chain dysfunction. These scenarios are: mtDNA attrition by exogenously stimulated topoisomerase DNA cleavage, unbalancing of mitochondrial and nuclear transcription by direct effects on mitochondrial transcription, and contributions to enhanced mtDNA entanglement and recombination.
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Physiological functions of mitochondrial topoisomerases
Human mtDNA is a closed, double-stranded DNA circle (Iborra et al., 2004; Lawrence et al., 1996) , although more complex topological structures are found in certain post-mitotic tissues of aged humans . A recent survey of the topology of mammalian mtDNA has revealed more than 25 distinct topological forms of mtDNA also including DNA/RNA hybrids and variety of single stranded DNA molecules (Kolesar et al., 2013) . Strand separation during transcription and replication of the closed double stranded mtDNA form creates topological stress that interferes with these processes unless that stress is released in a timely fashion. The only enzymes capable of performing this task are topoisomerases (Wang, 2002) . Three topoisomerases have been found in mammalian mitochondria, two enzymes catalysing the transient cleavage and ligation of single stranded DNA (mitochondrial topoisomerases I and IIIα) and one enzyme catalysing cleavage and ligation of both strands of the DNA double helix (mitochondrial topoisomerase IIβ). All three enzymes are encoded in the nuclear genome. Currently, very little is known about the role of these enzymes in mtDNA metabolism and maintenance. However, it appears that their biological functions differ markedly from those of the corresponding enzymes in the cell nucleus.
Mitochondrial topoisomerase I (TOP1MT) is the only known mitochondrial topoisomerase encoded by a separate gene. Splitting of the TOP1 gene into nuclear and mitochondrial paralogs is highly conserved in vertebrates (Zhang et al., 2001 (Zhang et al., , 2004 (Zhang et al., , 2007 and reflects a functional specialisation: Nuclear TOP1 is incompatible with mtDNA transcription/replication, while TOP1MT is unable to interact with nuclear chromosomes (Dalla Rosa et al., 2009 ). TOP1MT catalyses the transient cleavage and ligation of one strand of the DNA double helix, thereby providing the major activity for relaxation of mtDNA supercoils. TOP1MT DNA-cleavage activity is clustered in an mtDNA region downstream of the displacement loop (D-loop) (Zhang and Pommier, 2008) that contains an additional DNA strand (7S DNA). 7S DNA is either a prerequisite or a side product of mtDNA replication (Falkenberg et al., 2007) . Depletion of 7S DNA upon inhibition of TOP1MT (Zhang and Pommier, 2008) suggests an involvement of the enzyme in D-loop maintenance or replication. However, an essential role of TOP1MT in mtDNA maintenance is unlikely, since TOP1MT −/− mice express mtDNA-encoded proteins (Douarre et al., 2012) . In the cell nucleus, TOP1 is an essential cofactor promoting rRNA-and mRNA transcription (Christensen et al., 2002a; Kretzschmar et al., 1993; Zhang et al., 1988) . In mitochondria, TOP1MT is not essential for mtDNA-transcription. On the contrary, it acts as a negative regulator of mtDNA transcription. This function is not linked to the mito-biogenic nuclear programme, indicating a direct, intra-mitochondrial regulation mechanism (Sobek et al., 2014) . The negative impact of TOP1MT on mtDNA transcription involves a direct interaction with mitochondrial RNA polymerase and probably the removal of supercoils from mtDNA, as it is dependent on catalytic activity (Sobek et al., 2014) . DNA supercoiling is a known requirement for transcription initiation in bacteria and yeast (Drolet, 2006; Schultz et al., 1992) . mtDNA harbours a certain base line level of supercoiling (Kolesar et al., 2013) , which is most probably created in the course of compaction by mitochondrial transcription factor A (TFAM) (Kaufman et al., 2007; Pohjoismaki et al., 2006) . TFAMmediated mtDNA compaction and bending is required for the assembly of transcription complexes (Hallberg and Larsson, 2011) . TOP1MT possibly counteracts mitochondrial transcription initiation by reducing supercoiling below the level that permits optimal transcription. TOP1MT is up regulated in cellular stress responses (Goto et al., 2006) and cancer cells (Zoppoli et al., 2011) suggesting an involvement in stress-adaptation of respiratory capacity and the Warburg effect. However, this seems not the only function: TOP1MT −/− murine embryonic fibroblasts (MEFs) exhibit a complex pattern of mitochondrial dysfunction including hyper-fusion and constitutive retrograde activation of the nuclear mito-biogenic programme (Douarre et al., 2012) . The mitochondrial dysfunctions of TOP1MT −/− MEFs cannot be abolished by expressing TOP1MT (Sobek et al., 2014) indicating an essential and constitutive role of the enzyme in mtDNA maintenance during development, which is possibly related to the principal ability of TOP1 to process RNA/DNA hybrids, suppress R-loops (Tuduri et al., 2009 ) and stabilise circular mini-chromosomes (Trigueros and Roca, 2001) . Mitochondrial topoisomerases IIIα (TOP3A) is created by alternative translation initiation of a common transcript coding for nuclear and mitochondrial representatives of the enzyme . Currently, it is not known how alternative translation of TOP3A is regulated to control the relative amounts of nuclear and mitochondrial isoforms made from the common transcript. In the nucleus TOP3A acts on single stranded DNA transiently disengaged from the double helix (DNA solenoids) and plays an essential role in nuclear transcription by resolving DNA solenoids formed upon strand separation (Wang, 2002) . TOP3A seems to be a sufficient topoisomerase co-factor of mtDNA transcription, inasmuch as it is capable of upholding base line levels of mitochondrial transcripts in the absence of TOP1MT and TOP2B (Sobek et al., 2014) . TOP3A deficiency causes a depletion of mtDNA in male germ-line stem cells of Drosophila (Wu et al., 2010) pointing to an essential role in mtDNA maintenance, which is possibly linked to its presumed interaction with Twinkle helicase (see: section 2.3). However, currently it is not clear which functional deficit(s) cause this phenotype and whether it is due to deficiency of nuclear or mitochondrial products of the TOP3A gene. Moreover, the relevance of this finding with respect to mammalian mtDNA maintenance is questionable, since the machinery supporting these functions is very different in insects.
Topoisomerase IIβ (TOP2B) is the only known type II topoisomerase present in mitochondria, which is able to catalyse cleavage, passage and ligation of both strands of the DNA double helix. In the cell nucleus, TOP2B plays an essential role in transcriptional activation (Haffner et al., 2010; Ju et al., 2006) or repression (Tiwari et al., 2012) of certain gene loci, while chromosome condensation and segregation is exclusively supported by the other isoform topoisomerase IIα (TOP2A) (Grue et al., 1998; Linka et al., 2007) . Mammalian mitochondria contain a proteolytic derivative of TOP2B, which lacks the entire N-terminal domain of the enzyme (Low et al., 2003) . The N-terminal domain is the portion most divergent between TOP2A and TOP2B. It is responsible for recruiting TOP2B and TOP2A to isoform-specific tasks (Linka et al., 2007) but is dispensable for the enzymes' basic catalytic activities (Jensen et al., 1996) . Therefore, the N-terminally truncated, mitochondrial form of TOP2B is expected to be fully active in terms of cleavage, passage and ligation of DNA double strands, and could in principle be the enzyme separating intertwined mtDNA molecules that are inadvertently formed during replication (Wang, 2002) . However this seems not to be the case, since the degree of mtDNA-intertwining as well as the rate of mtDNA-transcription are normal in TOP2B −/− MEFs. Consequently, there must exist another enzyme activity in mitochondria that catalyses the separation of intertwined mtDNA molecules (see also section 2.3). We recently observed that TOP2B is significantly up-regulated in TOP1MT −/− MEFs and capable of maintaining increased levels of mtDNA transcription in the absence of TOP1MT (Sobek et al., 2014) , which possibly indicates a redundant role in the removal of negative DNA supercoils that are generated during mtDNA transcription and normally removed by TOP1MT.
2. Possible contributions of topoisomerases to age-related alterations in mtDNA homeostasis 2.1. mtDNA attrition by chronic exogenous "poisoning" of mitochondrial TOP1 and TOP2
Many compounds induce breaks in the DNA backbone through interference with the cleavage/ligation reaction of TOP1 and/or TOP2. Such compounds attenuate the ligation step of topoisomerases and thereby prolong the half-life of a catalytic intermediate consisting of a DNA break with topoisomerase covalently attached to the free 3′-or 5′-phosphate of the break. Such topoisomerase-linked DNA breaks are not readily recognised as DNA damage and consequently are less efficiently repaired than other DNA breaks (Deweese and Osheroff, 2009a; Pommier et al., 2006; Soubeyrand et al., 2010) . Substances inducing DNA breaks by inhibiting the ligation step of TOP1 or TOP2 are termed topoisomerase poisons because they turn the entire topoisomerase complement of a cell into a DNA-damaging agent. Topoisomerase poisons encompass a large and heterogeneous group of chemical compounds. Many widely prescribed anti-cancer drugs act by poisoning mammalian TOP2. These include the podophyllotoxins etoposid (VP16) and teniposide (VM26), the anthracyclins doxo-and daunorubicine, the phenathracene Mitoxantrone and the aminoacridine m-Amsacrine (Liu, 1989; Nitiss, 2009; Pommier et al., 2010) . TOP2 is also poisoned by various natural alkaloids produced by fungi or plants. Typical examples are the plant alkaloid Lycobetain (Barthelmes et al., 2001 ) and the fungal toxin Alternariol, which is a frequent carcinogenic food contaminant (Fehr et al., 2009 ). TOP2 poisoning is also an established carcinogenic mechanism of 1,4-benzoquinone metabolites derived from industrial waste products containing benzene (Lindsey et al., 2005) . Interestingly the widely prescribed analgesic drug Acetaminophen is likewise metabolised to a 1,4-benzoquinone derivative that effectively poisons mammalian TOP2 and possibly triggers liver carcinogenesis in humans (Bender et al., 2004) . Moreover, certain bioflavonoids that are constituents of normal human diet exhibit a strong TOP2-poisoning activity. Most notably, the isoflavone Genistein contained in soybeans is a strong poison of TOP2B (Bandele and Osheroff, 2007) . Habitual consummation of soy-based dietary supplements or food fortified with isoflavones in purified form is assumed to raise serum levels of Genistein up to 10 μM (Nielsen and Williamson, 2007) , a concentration that effectively poisons TOP2B in cultured human cells (Kalfalah et al., 2011) . It is assumed that Genistein consumed at high doses during pregnancy plays a role in triggering infant leukaemia (Ross, 2000; Ross and Kasum, 2002) . Poisoning of TOP1 is the established mechanism of a group of widely prescribed anti-cancer drugs derived from the plant alkaloid camptothecin (Nitiss, 2009; Pommier et al., 2010) . TOP1-poisoning is also a side effect of the Dihydropyridine Dexniguldipine, a drug prescribed as a calcium antagonist . The isoflavone Quercetin contained in nuts and coffee is an effective TOP1-poison (Boege et al., 1996) . Genistein is highly enriched in certain food supplements, but it is not known whether its bioavailability upon consummation of such supplements is sufficient to induce TOP1-poisoning in humans.
In addition to the above chemical compounds, various exogenously induced DNA base modifications can inhibit the ligation step of TOP1 or TOP2 in vitro, when placed next to a strong cleavage site in a synthetic DNA substrate (Deweese and Osheroff, 2009b; Kingma and Osheroff, 1998; Leteurtre et al., 1994; Pourquier et al., 1997 Pourquier et al., , 2000 Sabourin and Osheroff, 2000; Yeh et al., 1994) . Thus, ephemeral DNA lesions such as base oxidations or abasic sites that are normally rapidly removed can trigger topoisomerase-linked breaks in the DNA backbone that are not or only slowly repaired. In live mammalian cells, topoisomerasecoupled DNA breaks are indeed induced next to oxidised DNA bases (e.g. 8-oxo-guanine), and enhanced DNA-oxidation increases the formation of TOP1-or TOP2-linked DNA breaks and/or results in the immobilisation of the enzymes on nuclear DNA (Daroui et al., 2004; Lanza et al., 1996; Mielke et al., 2004 Mielke et al., , 2007 Sordet et al., 2004) . These observations indicate that oxidised DNA-bases can indeed trigger TOP1/2 poisoning in living mammalian cells, although the precise mechanism of this effect remains unclear.
Besides topoisomerase poisons there also exist compounds that inhibit the catalytic activity of TOP1 and/or TOP2 without inducing DNA breaks. Such catalytic topoisomerase inhibitors affect cells by withdrawing topoisomerase activity. The most potent catalytic TOP2-inhibitors are synthetic bisdioxopiperazines such as Dexrazoxane (ICRF 187) that effectively inhibit cell cycle progression, chromosome condensation and chromosome segregation (Gorbsky, 1994) by suppressing TOP2A activity essential for these processes (Christensen et al., 2002b; Grue et al., 1998; Linka et al., 2007) . Similar properties have been demonstrated in napthoquinone metabolites of natural compounds from walnut (Jimenez-Alonso et al., 2008) and in anthocyanidins such as Delphinidin, natural constituents of red coloured fruits that are highly enriched in food supplements based thereon. All these substances inactivate TOP2 at μM concentrations without inducing DNA cleavage (Habermeyer et al., 2005; Kalfalah et al., 2011) . Anthocyanidins also act as catalytic inhibitors of TOP1 (Habermeyer et al., 2005) and strong catalytic TOP1-inhibitory activity has also been observed in compounds derived from bioflavonoids contained in nuts and coffee (Boege et al., 1996) .
Many substances that poison nuclear topoisomerases also target mitochondrial topoisomerases (de la Loza and Wellinger, 2009; Lin and Castora, 1991; Rowe et al., 2001; Zhang and Pommier, 2008) , which possibly plays a role in chronic degeneration of certain tissues. For instance, myocardial degenerative side effects of anthracyclines are mediated by poisoning of TOP2B, which is accompanied by a selective alteration in the transcriptome related to oxidative phosphorylation and mitochondrial biogenesis . The restriction of damage to the mito-biogenic gene programme suggests that mitochondrial TOP2B probably is the primordial mediator of the myocardial degenerative effect. If nuclear TOP2B were the target, one would expect damage in gene programmes typically regulated in the nucleus by TOP2B (Tiwari et al., 2012) . Mitochondrial topoisomerases may not only be relevant targets and/or crucially affected bystanders of topoisomerase poisoning, but also seem to have a sensitivity spectrum different from their nuclear counterparts. For instance, they are targeted by quinolones. Quinolones are clinically established antibiotics that act through poisoning bacterial TOP2 (gyrase) but do not target the isoforms of mammalian TOP2 found in the nucleus. Nevertheless, quinolones deplete mtDNA (Castora et al., 1983) and induce proteinmediated mtDNA breaks (Lawrence et al., 1996; Li and Liu, 1998 ) in mammalian cells. One possible explanation for this observation is that loss of the N-terminal domain renders TOP2B sensitive to quinolones in mammalian mitochondria, while full length TOP2B present in the nucleus is resistant to gyrase inhibitors. On the other hand, there may well exist another, as yet unknown, mitochondria-dedicated mammalian type II topoisomerase that shares sufficient similarities with bacterial gyrase to be sensitive to quinolones.
It must be assumed that normal human life encompasses a certain level of constitutive topoisomerase poisoning due to the dietary intake of bioflavonoids such as Genistein (Nielsen and Williamson, 2007; Ross and Kasum, 2002) and the inadvertent exposure to industrial waste and pharmaceuticals giving rise to benzoquinone metabolites (Bender et al., 2004; Lindsey et al., 2005) or fungal TOP2-poisons such Alternariol that are obligatory food contaminants (Fehr et al., 2009) . It is currently assumed that such chronic low-dose exposure of gravid mothers contributes to the incidence of infant leukaemia (Lindsey et al., 2005; Ross, 2000; Strick et al., 2000) . One should entertain the idea that it also (and more significantly) contributes to chronic mtDNA attrition associated with ageing. Moreover, established oxidative processes of chronic mtDNA attrition are interlinked with topoisomerase-mediated mtDNA-damage, inasmuch as much as oxidative DNA base modifications such as 8-oxoguanine, known to trigger DNA cleavage through topoisomerase I and II (Daroui et al., 2004; Kingma and Osheroff, 1998; Lanza et al., 1996; Mielke et al., 2004 Mielke et al., , 2007 Pourquier et al., 1999; Sordet et al., 2004) , are much more frequent in mtDNA than in nuclear DNA (Hoffmann et al., 2004; Richter, 1995) . Although oxidised nucleotides can be effectively repaired in mtDNA, there is evidence that they are a major source of double strand breaks (David et al., 2007) . In mouse muscle such breaks promote large mtDNA deletions similar to those found in humans (Srivastava and Moraes, 2005) . In summary these observations support the hypothesis that topoisomerase-mediated DNA-breaks indeed contribute to age-related mtDNA attrition.
Unbalancing of mitochondrial/nuclear transcription by oxidative inactivation, catalytic inhibition or inadequate expression of TOP1MT
Four of the five respiratory chain complexes are composed of a mix of nuclear and mtDNA-encoded components and become unstable when the stoichiometry of these components is disrupted. Consequently, nuclear and mitochondrial transcriptions have to be efficiently coordinated. Several proteins involved in that coordination have a notable impact on lifespan and are involved in age-related mitochondrial disorders (Finley and Haigis, 2009 ). Currently, mitochondrial/nuclear coordination of transcription is mostly assigned to retrograde signalling loops, through which the mito-biogenic programme in the nucleus can be activated by dysfunctional or overworked mitochondria via the release of Ca 2+ (Rohas et al., 2007) , ROS (Cunningham et al., 2007) or insufficient ATP-production . Given the coupling of mtDNA transcription and replication (Falkenberg et al., 2007) , these mechanisms also control the amount of mtDNA in the cell, which ultimately adapts energy production to requirements (Rocher et al., 2008) . In addition, there exist mechanisms of direct regulation of mtDNA transcription allowing for an adjustment of the respiratory stoichoimetry to the local reduction state at the inner mitochondrial membrane (Enriquez et al., 1999) , which are considered the most plausible reasons for mitochondria to retain any genes at all (Allen, 1993; Lane, 2014) . Redox-sensitive mitochondrial transcription factors that could possibly perform such a local regulatory function have not been identified yet, although there is ample indirect evidence of their action (Enriquez et al., 1999) . There is a strong case for TOP1MT being one of those hitherto elusive factors. We have shown that TOP1MT acts as a dominant negative regulator of mtDNA transcription and this function requires the enzyme to be active in terms of relaxation of DNA supercoils (Sobek et al., 2014) . It has long been known that TOP1 activity is liable to attack by thiol-reactive compounds on essential cysteine residues within the enzyme core (Montaudon et al., 2007) , which are conserved in TOP1MT (Zhang et al., 2001 (Zhang et al., , 2004 . Plant mitochondrial topoisomerase I is inactivated by thiol-reactive compounds and oxidised glutathione (Konstantinov et al., 2001) . Our own unpublished experiments in vitro and in organello indicate that this also holds true for human TOP1MT. Most notably, TOP1MT becomes inactivated in the living cell, when superoxide levels within the mitochondrial matrix are raised by respiratory chain blockade. In summary these observations support the model of a double negative loop, by which TOP1MT directly regulates mtDNA-transcription in a redox-sensitive fashion, as schematized in Fig. 1 . We propose that increases in intra-mitochondrial reductive potential (e.g. due to overloading or dysfunction of the respiratory chain) attenuate TOP1mt activity through oxidation of essential cysteine residues in the enzyme core. Alternatively, aberrant di-sulphide bridges between these residues could be induced by oxidised glutathione. Direct or indirect oxidative inactivation of TOP1MT then interrupts the repressive effect of the enzyme on the transcription machinery, thus increasing oxidative capacity (Sobek et al., 2014) . The above mechanism may play a role in the local adaptation of respiratory capacity in cases where the energetic demand is not homogeneously distributed within the cell body such as in liver cells and neuron cells with long axons (Enriquez et al., 1999) . For such adaptive effects to act beneficially it is required that enhanced mitochondrial transcription following TOP1MT inactivation triggers corresponding increases in the transcription of nuclear encoded respiratory subunits. The mechanism is bound to become mal-adaptive, when retrograde regulation of the mito-biogenic response in the nucleus becomes defective. This is typically the case in aged mammalian skeletal muscle exhibiting a defective retrograde mito-biogenic response due to dysfunctions of AMPKα2, components of the mTOR pathway (Li et al., 2012; Qiang et al., 2007) and declining intracellular NAD + (Gomes et al., 2013) . One would expect that in the latter situation, redoxsensitive local up-regulation of mtDNA-transcription will cause a dissociation of nuclear and mitochondrial transcription leading to an imbalance between respiratory complexes containing mtDNA encoded components and respiratory complexes entirely made up of nuclear encoded subunits. A similar imbalance would be expected, when there is too much TOP1MT activity expressed. We have demonstrated that overexpression of TOP1MT in human cells lowered mitochondrial transcripts, depleted respiratory complexes I, III and IV, decreased cell respiration and raised superoxide levels (Sobek et al., 2014) , which demonstrates that an inadequate increase in TOP1MT activity indeed has the potential to induce mitochondrial dysfunctions. Imbalance of respiratory complexes due to selective loss of mtDNA-encoded respiratory subunits has recently been observed in ageing skeletal muscle, where declining NAD + induces a pseudo-hypoxic state through altered expression of c-Myc-regulated mitochondrial genes (Gomes et al., 2013) , one of which is TOP1MT (Zoppoli et al., 2011) . These observations suggest that inadequate TOP1MT expression/activity could indeed contribute to age-associated imbalances in the expression of nuclear and mtDNA encoded respiratory subunits in mammalian tissues. It should finally be noted that inadequate TOP1MT activity could also be due to habitual chronic exposure to catalytic TOP1 inhibitors such as Naphtoquinones or Anthocyanidins possibly contained in food supplements (see section 2.1).
Role topoisomerases in age-related increases of recombination and intertwinement of mtDNA
mtDNA is in principle a double-stranded DNA-circle. However, based on this structure, it can assume topologies ranging from simple supercoiled circular monomers and linear intermediates to head-totail circular dimers, intertwined circles, and complex multimeric networks interconnected by holiday junctions and entanglements as well as DNA/RNA hybrids and variety of single stranded DNA molecules (Kolesar et al., 2013) . The most complex, branched and multiple-entangled forms of mtDNA are typically found in adult human post-mitotic organs that have a constantly high energy demand, i.e. brain and myocardium (Kajander et al., 2001; Pohjoismaki et al., 2009) . In rodents and young humans these same tissues exhibit a simple monomeric circular mtDNA-topology (Pohjoismaki et al., 2010) . The adult-type branched form of mtDNA is acquired early in life and leads to an increase in copy number (Pohjoismaki et al., 2010) . It is unclear, whether that age-related complexity switch in mtDNA topology constitutes an adaptive or developmental process Pohjoismaki et al., 2010) , or the first step in a sequence of recombination and faulty repair driving chronic mtDNA attrition during ageing (Kajander et al., 2001; Krishnan et al., 2008) . The mechanisms leading to the complex mtDNA topology in aged human myocardium are multifactorial and not completely understood . However, these complex mtDNA topologies, namely multiple intertwined circles and Holliday junctions, exhibit features suggesting that topoisomerases are involved in their formation.
Each round of replication of a closed circular DNA molecule inadvertently generates a set of intertwined daughter molecules, the separation of which requires a type II topoisomerase capable of passing both strands of the DNA double helix through another double helical DNA segment (Marini et al., 1980) . Separation of intertwined mtDNA molecules may also be catalysed by a type I topoisomerase enabling sequential passage of single DNA strands through each other (Brown and Cozzarelli, 1981; Tse and Wang, 1980) , but the latter reaction requires high substrate concentrations not provided in nucleoids containing on average just one mtDNA molecule (Kukat et al., 2011) . Therefore, it is probably a type II topoisomerase that controls the state of mtDNA intertwinement in vivo. TOP2B is the only type II topoisomerase so far found in mammalian mitochondria (Low et al., 2003) . However, TOP2B is not essentially involved in mtDNA maintenance (Sobek et al., 2014) , suggesting that at least one more type II topoisomerase controls the state of mtDNA intertwinement. This other type II topoisomerase could be an unknown, mitochondria-dedicated protein that possibly shares similarities with bacterial gyrase (see 2.1), or it could be TOP2A, which is the only other known type II topoisomerase present in mammals. So far, TOP2A has not been detected in mitochondria and artificial targeting of TOP2A to mitochondria leads to rapid mtDNA depletion (our own unpublished observation). However, even if TOP2A should be the enzyme providing the elusive activity catalysing the separation of intertwined mtDNA molecules, then this activity would be available only in proliferative tissues, since TOP2A is expressed from a single gene, which is tightly repressed in non-proliferative cells and tissues (Isaacs et al., 1996; Turley et al., 1997) . To our knowledge there exists no alternative transcriptional control of TOP2A that would allow for an expression in non-proliferative tissues, and the expression of TOP2A protein is tightly restricted to proliferative cells, tissues and tissue compartments (Kreipe et al., 1993; Meyer et al., 1997; Turley et al., 1997) . Therefore, age-related increases in mtDNA intertwinement observed in old, non-proliferative tissues could reflect a lack of TOP2A, which leads to the gradual accumulation of intertwined mtDNA molecules in the course of ongoing mitochondrial replication. This would be a degenerative process. Alternatively, enhanced entanglement of mtDNA could be an adaptive process that increases the number of mtDNA copies per nucleoid to support age-related increases in energy demand or compensate increased reductive load and age-related mtDNA-defects by an increase in redundancy . Intertwinement of multiple mtDNA molecules would be a plausible mechanism for condensation and stabilisation of such larger nucleoidal genomes, given that a very similar mechanism, namely entanglements of sister chromatids, is used in mammals for condensation and stabilisation of mitotic chromosomes (Bauer et al., 2012; Kawamura et al., 2010; Samejima et al., 2012) . A third possible explanation for the enhanced occurrence of multiple intertwined mtDNA molecules in old post mitotic tissues is provided by the recent observation that such structures are increased in mammalian cells following experimental mtDNA depletion, and therefore, may be important for supporting conditions of enhanced mtDNA replication (Kolesar et al., 2013) . Finally, it could be imagined that disentanglement of newly replicated mtDNA circles could be attenuated by habitual chronic ingestion of catalytic TOP2 inhibitors such as Naphtoquinones or Anthocyanidins contained at high concentrations in certain food supplements (see section 2.1).
Another feature of adult-type complex myocardial mtDNA topologies pointing at an oblique involvement of topoisomerases is the presence of branched recombination intermediates (Holliday junctions). In contrast to tetraplasmic maternal/paternal mtDNA recombination intermediates observed in skeletal muscles of patients with rare Dloop mutations (Kraytsberg et al., 2004; Zsurka et al., 2005) , the complex mtDNA forms in aged myocardium appear to be the result of recombination between identical mtDNA molecules. mtDNA molecules do not exchange between nucleoids (Gilkerson et al., 2008) and germ line recombination of mtDNA in the absence of the above mentioned D-loop mutations is an extremely rare event (Hagstrom et al., 2013) . Therefore, the complex mtDNA forms observed in aged mammalian tissues must arise from somatic recombination of mtDNA molecules within the same nucleoid. These structures are thought to arise from an alternative, recombination-driven mode of mtDNA replication and/or the faulty repair of stalled replication complexes (Pohjoismaki et al., 2010 . It seems conceivable, that mtDNA polyploidy due to incomplete separation of intertwined replication products provides an environment favouring such events or is even a prerequisite thereof. The incidence of recombination intermediates in mtDNA is closely associated with the activity of the mitochondrial DNA helicase Twinkle, which is essential for mtDNA maintenance and regulates mtDNA copy number (Tyynismaa et al., 2004) . Twinkle overexpression in mouse leads to a dramatic increase in complex mtDNA forms containing Holliday junctions in heart, skeletal muscle and brain (Pohjoismaki et al., 2009 ). There exist various catalytically impaired Twinkle mutations associated with recessive hereditary cerebellar dysfunction in humans (Nikali et al., 2005) . Such pathogenic mutations cause Twinkle to induce mtDNA deletions (Tyynismaa et al., 2005) and replication stalling (Farge et al., 2008) ultimately leading to complex mtDNA rearrangements and late onset mitochondrial disease in mouse (Tyynismaa et al., 2005) . Surprisingly, humans harbouring such pathogenic Twinkle mutations lack Holliday junctions in myocardial mtDNA (Pohjoismaki et al., 2010) . In summary, these observations suggest that mtDNA recombination is determined by Twinkle in concert with an as yet unidentified cofactor that complements or enhances dysfunctions of the helicase in a variable manner. The situation is reminiscent of the role of RecQ helicases in nuclear DNArecombination associated with replication stalling. Mutations in three members of this enzyme family are associated with genome instability in human progeroid syndromes (Bloom's, Werner's and RothmundThomson's syndrome) (Hanada and Hickson, 2007; Wu and Hickson, 2001) . The RecQ helicase involved in Bloom's syndrome forms stable complexes with TOP3A, and interaction of these two classes of proteins is required to maintain genomic stability by preventing inappropriate recombination in all eukaryotic species where this has been studied (Wu and Hickson, 2001; Wu et al., 2000) . Most notably, the complex of Bloom's helicase and TOP3A is the most potent resolvase of Holliday junctions in the nuclear genome (Hickson and Mankouri, 2011) . Given that Holliday junctions have been observed in mitochondria and no other enzyme that could resolve these structures has yet been found in the organelle, it seems a plausible surmise that Twinkle is the mitochondrial equivalent of Bloom's helicase and likewise cooperates with TOP3A to resolve Holliday junctions in mtDNA. Under this premise, enhanced mtDNA recombination in aged human myocardium could be due to an altered balance of helicase and topoisomerase activity. Incidentally, that mechanism could well be responsible for the loss of mtDNA observed in TOP3A deficient Drosophila (Wu et al., 2010) .
Concluding remarks
Theoretical considerations suggest that DNA topoisomerases are as essential for mtDNA maintenance and function, as they are for corresponding processes in the cell nucleus. A number of observations indicate that dysfunction or exogenous disruption of these enzymes could be involved in chronic mtDNA attrition and age-related decline of mtDNA homeostasis. This possibility has so far not been systematically investigated. Inclusion of DNA topoisomerase into current concepts on mitochondrial ageing processes could help to understand hitherto unclear phenomena and observations in the age-related decline of mtDNA homeostasis.
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